Balyasny Asset Management L.P.

Position in ORIC — Oric Pharmaceuticals, Inc.

CIK 1218710 Chicago, IL

Position in ORIC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$262,096

-$6,374,323 QoQ

Shares Held

24,201

-95.4% QoQ

Ownership

0.023%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#108

of 179 holders

Holding Since

Sep 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names. ORIC ranks #162 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	1,665,102	$221,008,988
2	INSM	INSMED Inc	1,326,430	$141,423,966
3	BBIO	BridgeBio Pharma, Inc.	1,230,052	$91,614,272
4	ABVX	Abivax S.A.	603,840	$80,467,718
5	VRTX	Vertex Pharmaceuticals Inc / Ma	145,005	$72,028,333
6	TNGX	Tango Therapeutics, Inc.	2,016,379	$63,032,007
7	CYTK	Cytokinetics Inc	711,676	$60,627,678
8	BMRN	Biomarin Pharmaceutical Inc	1,054,613	$60,344,955

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$262,096	24,201	-95.4%	Shares	Sole	2026-08-14
2026-03-31	$6,636,419	523,790	-44.9%	Shares	Sole	2026-05-15
2025-12-31	$7,772,750	950,214	-37.5%	Shares	Sole	2026-02-17
2025-09-30	$18,231,768	1,519,314	-14.5%	Shares	Sole	2025-11-14
2025-06-30	$18,044,101	1,777,744	-11.4%	Shares	Sole	2025-08-14
2025-03-31	$11,200,577	2,007,272	+29.1%	Shares	Sole	2025-05-15
2024-12-31	$12,550,948	1,555,260	+37.5%	Shares	Sole	2025-02-14
2024-09-30	$11,593,426	1,131,066	+9546.6%	Shares	Sole	2024-11-14
2023-03-31	$66,832	11,725	-13.5%	Shares	Sole	2023-05-15
2022-09-30	$43,382	13,557	—	Shares	Sole	2022-11-15
No filing history on record for this holder in this stock.